July 1, 2023 Comments Off on New patent for Astellas drug CRESEMBA Posted in: Patent Added Annual Drug Patent Expirations for CRESEMBA Cresemba is a drug marketed by Astellas and is included in two NDAs. It is available from one supplier. There are four patents protecting…
The post New patent for Astellas drug CRESEMBA appeared first on Drug…
July 1, 2023 Comments Off on New patent lawsuit: Galderma Laboratories, L.P. v. Dr. Reddys Laboratories, Ltd. – Drug patent: 8,206,740 Posted in: Drug Patent Litigation A new lawsuit citing drug patent 8,206,740 has been filed. The small molecule drug covered by this patent is ORACEA. See more details at Galderma Laboratories, L.P. v. Dr. Reddys…
The post New patent lawsuit: Galderma Laboratories, L.P. v. Dr. Reddys L…
